Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue
- 17 September 2004
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 63 (1) , 13-18
- https://doi.org/10.1002/pros.20156
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Serum Pro Prostate Specific Antigen Improves Cancer Detection Compared to Free and Complexed Prostate Specific Antigen in Men With Prostate Specific Antigen 2 to 4 Ng/MlJournal of Urology, 2003
- Total and Gleason Grade 4/5 Cancer Volumes are Major Contributors of Human Kallikrein 2, Whereas Free Prostate Specific Antigen is Largely Contributed by Benign Gland Volume in Serum From Patients With Prostate Cancer or Benign Prostatic BiopsiesJournal of Urology, 2003
- ErrataJournal of Urology, 2003
- Discrimination of Benign From Malignant Prostatic Disease by Selective Measurements of Single Chain, Intact Free Prostate Specific AntigenJournal of Urology, 2002
- Prediction of Prostate Volume Based on Total and Free Serum Prostate–Specific Antigen: Is It Reliable?European Urology, 2000
- Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasiaUrology, 1999
- TNM classification of malignant tumors, fifth edition (1997)Cancer, 1997
- Serum Prostate-Specific Antigen in a Community-Based Population of Healthy MenJAMA, 1993
- An Abbreviated Standard Procedure for Accurate Tumor Volume Estimation in Prostate CancerThe American Journal of Surgical Pathology, 1992
- Zonal Distribution of Prostatic AdenocarcinomaThe American Journal of Surgical Pathology, 1988